Table 1 Descriptive and comparative statistics: psoriatic patient versus control group
Parameters | Psoriatic patients n = 180 | Control group n = 180 | p values |
|---|---|---|---|
Age (years) | 50 (21.0–65.0) | 48.0 (29.0–65.0) | 0.623 |
Anthropometric variables | |||
 Weight (kg) | 85.7 ± 20.1 | 84.1 ± 21.7 | 0.447 |
 Height (m) | 1.69 (1.49–1.92) | 1.70 (1.50–1.85) | 0.878 |
 BMI (kg/m2) | 30.2 ± 6.1 | 29.6 ± 7.3 | 0.422 |
  Normal weight n (%) | 40 (22.2 %) | 55 (30.6 %) | 0.094 |
  Overweight n (%) | 55 (30.6 %) | 47 (26.1 %) | 0.413 |
  Obesity n (%) | 85 (47.2 %) | 78 (43.3 %) | 0.525 |
 WC (cm) males | 108.8 ± 17.0 | 96.3 ± 21.5 | <0.001 |
 WC (cm) females | 110.5 ± 26.3 | 95.2 ± 24.2 | 0.002 |
Metabolic profile | |||
 SBP (mmHg) | 130.0 (100.0–165.0) | 125.0 (95.0–165.0) | 0.010 |
 DBP (mmHg) | 80.0 (50.0–100.0) | 75.0 (50.0–100.0) | 0.008 |
 Glucose (mg/dl) | 105.0 (65.0–197.0) | 96.0 (61.0–190.0) | 0.026 |
 Total cholesterol (mg/dl) | 197.5 (97.0–315.0) | 171.0 (102.0–332.0) | 0.025 |
 HDL cholesterol (mg/dl) | 43.3 ± 11.0 | 45.7 ± 7.9 | 0.023 |
 LDL cholesterol (mg/dl) | 132.6 ± 44.7 | 121.7 ± 51.8 | 0.049 |
 Triglycerides (mg/ml) | 164.0 (36.0–402.0) | 139.0 (66.0–273.0) | 0.009 |
 AST (U/l) | 28.0 (10.0–94.0) | 27.0 (5.0–65.0) | 0.013 |
 ALT (U/l) | 29.0 (7.0–150.0) | 25.0 (3.0–63.0) | 0.022 |
 CRP levels (ng/ml) | 3.1 (0.1–16.2) | 1.1 (0.0–3.9) | <0.001 |
Bioelectrical variables | |||
 R (Ohm) | 504.5 ± 85.8 | 492.9 ± 87.2 | 0.215 |
 Xc (Ohm) | 45.4 ± 9.2 | 50.1 ± 10.4 | <0.001 |
 PhA (°) | 5.2 ± 1.0 | 5.8 ± 0.7 | <0.001 |